Olanzapine Injection, Powder, For Solution
Product Images NDC 72843-576

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 72843-576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ubi Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (Olanzapine for Injection 10 mg/vial)

This is a product information sheet for Olanzapine injection, a medication containing 10 mg of Olanzapine per vial. The inactive ingredients include lactose monohydrate and tartaric acid. Instructions on reconstitution with Sterile Water for Injection are provided, resulting in 5 mg of Olanzapine per mL. The manufacturer is UBI Pharma Inc. from Taiwan. The medication should be stored at controlled room temperature before and after reconstitution, and any unused portion should be discarded. The solution should appear clear and yellow. This medication is for intramuscular use only and should be protected from light.*

FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.